Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $291.3900 (4.29%) ($280.1600 - $292.6000) on Mon. May. 12, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.71% (three month average) | RSI | 39 | Latest Price | $291.3900(4.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.5% a day on average for past five trading days. | Weekly Trend | REGN declines -1.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XBI(38%) XLV(38%) QQQ(32%) SPY(30%) XLK(28%) | Factors Impacting REGN price | REGN will decline at least -1.355% in a week (0% probabilities). TLT(-6%) TIP(-3%) SHY(-3%) IGOV(-3%) VIXM(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.355% (StdDev 2.71%) | Hourly BBV | 0 () | Intraday Trend | 3.8% | | | |
|
1 - 5 Day Possible Target | $284.47(-2.37%) | Resistance Level | $293.21 | 5 Day Moving Average | $285.9(1.92%) | 10 Day Moving Average | $291.42(-0.01%) | 20 Day Moving Average | $293.21(-0.62%) | To recent high | -12.5% | To recent low | 4.3% | Market Cap | $30.896b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |